Correction: Neoadjuvant olaparib targets hypoxia to improve radioresponse in a homologous recombination-proficient breast cancer model.


[This corrects the article DOI: 10.18632/oncotarget.20936.].

More about this publication

  • Volume 11
  • Issue nr. 17
  • Pages 1573-1574
  • Publication date 28-04-2020

This site uses cookies

This website uses cookies to ensure you get the best experience on our website.